Clinical Trial: A Clinical Trial Comparing Low-Dose RT + Targeted Therapy+ Immunotherapy vs Targeted Therapy+ Immunotherapy Alone as Neoadjuvant Therapy in Operable HNSCC Patients.

U.S., June 28 -- ClinicalTrials.gov registry received information related to the study (NCT07040956) titled 'A Clinical Trial Comparing Low-Dose RT + Targeted Therapy+ Immunotherapy vs Targeted Therapy+ Immunotherapy Alone as Neoadjuvant Therapy in Operable HNSCC Patients.' on June 19.

Brief Summary: This study aimed to compare the efficacy of neoadjuvant low-dose radiotherapy combined with targeted therapy and immunotherapy versus targeted therapy and immunotherapy alone in patients with resectable head and neck squamous cell carcinoma.

Study Start Date: July 01

Study Type: INTERVENTIONAL

Condition: Head and Neck Squamous Cell Carcinoma Low-dose Radiotherapy Immunotherapy Targeted Therapy

Intervention: DRUG: Tislelizumab

200mg IV Q...